6 Needs context
Men with specific vasopressin receptor gene polymorphisms that reduce vasopressin responsiveness have higher rates of being unmarried or divorced.
"And so there's a particular variety of this polymorphism in the vasopressin receptors that males have um that make them non- less responsive to vasopressin. And these males are more likely to be either divorced or never been married, whereas males that don't have this polymorphism are more likely to be happily married." (said at 0:03:15)
The host refers to a well-known 2008 study of candidate gene associations involving the arginine vasopressin receptor 1A (AVPR1A) gene. That study found that men carrying one or two copies of a specific repeat variant (RS3 334 allele) scored lower on partner-bonding measures, were less likely to be married (more often unmarried or cohabiting), and reported more marital crises and lower marital quality as reported by their spouses. However, candidate gene association studies of complex social behaviors represent observational correlations rather than direct proof of reduced vasopressin responsiveness, and subsequent replication attempts have yielded inconsistent or conflicting results in different relationship contexts.
- supports: Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bondin… (Proceedings of the National Academy of Sciences of the United States of America 2008) · cited 461x in the literature
"Here, we report an association between one of the human AVPR1A repeat polymorphisms (RS3) and traits reflecting pair-bonding behavior in men, including partner bonding, perceived marital problems, and marital status, and show that the RS3 genotype of the males also affects marital quality as perceived by their spouses." (abstract, results, passage verified)
pubmedfull study (doi) - context: AVPR1A RS3 and relationship maintenance processes in newlywed couples. (Frontiers in psychology 2025)
"Across both approaches, results failed to support our predictions. In fact, the significant effects that did emerge were in the opposite direction from our predictions: people with at least one copy of allele 334 reported fewer marital problems and less interest in romantic alternatives; the number of short alleles was similarly positively associated with more dedication to the relationship and greater relationship satisfaction at the beginning of marriage." (abstract, results, passage verified)
pubmedfull study (doi)
Taking NSAIDs such as ibuprofen around resistance training workouts impairs muscle hypertrophy and growth.
"athletes will be like, "Oh my god, I don't want to be so sore after my workout. I'll take uh NSAIDs, right? I'll take like Advil, ibuprofen, whatever to facilitate recovery." And in fact, then they have less hypertrophy and they have less muscle growth as a result." (said at 0:22:12)
Evidence shows that regular, high over-the-counter doses of NSAIDs (such as 1,200 mg/day of ibuprofen) significantly attenuate muscle hypertrophy and strength adaptations in young, healthy adults undergoing resistance training. For example, a randomized controlled trial in young adults found that 8 weeks of daily ibuprofen intake reduced quadriceps hypertrophy compared to low-dose aspirin (3.7% vs. 7.5% increase in muscle volume). However, this effect is dose- and age-dependent: moderate daily doses (e.g., 400 mg/day) in young adults have not shown a significant negative impact on hypertrophy, and in older adults with chronic low-grade inflammation, daily NSAID use during resistance training unexpectedly enhanced muscle hypertrophy and strength gains.
- context: The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance t… (Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2008) · cited 96x in the literature
"We conclude that a moderate dose of ibuprofen ingested after repeated resistance training sessions does not impair muscle hypertrophy or strength and does not affect ratings of muscle soreness." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exer… (American journal of physiology. Regulatory, integrative and comparative physiology 2011) · cited 195x in the literature
"Over-the-counter doses of acetaminophen or ibuprofen, when consumed in combination with resistance training, do not inhibit and appear to enhance muscle hypertrophy and strength gains in older adults." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptati… (Acta physiologica (Oxford, England) 2018) · cited 90x in the literature
"The increase in m. quadriceps volume was similar between FW and WS, yet was (averaged across legs) greater in ASA (7.5%) compared with IBU (3.7%, group difference 34 cm 3 ; P = 0.029)... Maximal over-the-counter doses of ibuprofen attenuate strength and muscle hypertrophic adaptations to 8 weeks of resistance training in young adults." (abstract, results and conclusions)
pubmedfull study (doi)
The plasma half-life of supplemental vitamin C is approximately 1.5 hours.
"the half-life is like an hour and a half in plasma or something" (said at 0:24:55)
The plasma elimination half-life of vitamin C is strongly dose-dependent due to saturable renal reabsorption. At supra-physiological or high supplemental doses that exceed the renal threshold (plasma concentrations above approximately 70–100 µmol/L), excess ascorbic acid is rapidly filtered and excreted in the urine, resulting in a plasma elimination half-life of roughly 1.5 to 2 hours (measured at ~1.87 ± 0.40 hours in pharmacokinetic trials). However, at physiological dietary intakes or in depleted states, the sodium-dependent vitamin C transporter SVCT1 reabsorbs ascorbic acid in the renal tubules, leading to a much longer apparent half-life (several days to weeks) to conserve whole-body stores.
Metformin has been shown in short-term studies to possibly prevent cancer prophylactically.
"I think, you know, it has been shown, like you said, you know, it it can possibly prophylactically prevent cancer. So far, and and I think the the studies that have shown that um have been pretty short term." (said at 0:31:30)
Observational cohort and case-control studies have reported an inverse association between metformin use and cancer incidence in patients with type 2 diabetes. However, randomized clinical trial evidence has not confirmed a prophylactic or cancer-preventive effect. A collaborative meta-analysis of randomized controlled trials found no significant reduction in overall cancer incidence with metformin compared to control (RR 1.02, 95% CI 0.82–1.26). Furthermore, long-term randomized trial data from the Diabetes Prevention Program Outcomes Study across 21 years of follow-up showed no statistically significant reduction in total cancer incidence with metformin versus placebo (HR 0.90, 95% CI 0.73–1.10).
- contradicts: Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic revie… (Diabetologia 2012) · cited 183x in the literature
"Summary RRs for cancer outcomes in people randomised to metformin compared with any comparator were 1.02 (95% CI 0.82, 1.26) across all trials, 0.98 (95% CI 0.77, 1.23) in a subgroup analysis of active-comparator trials and 1.36 (95% CI 0.74, 2.49) in a subgroup analysis of placebo/usual care comparator trials." (abstract, results, passage verified)
pubmedfull study (doi) - context: Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis o… (Scientific reports 2015) · cited 145x in the literature
"Meta-analysis demonstrated that the use of metformin or thiazolidinediones was associated with a lower risk of cancer incidence (RR = 0.86, 95% CI 0.83-0.90, I(2) = 88.61%..." (abstract, results)
pubmedfull study (doi) - contradicts: Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence ove… (Cancer prevention research (Philadelphia, Pa.) 2025) · cited 12x in the literature
"After a median follow-up of 21 years, 546 participants (173 metformin, 182 ILS, and 191 placebo) were diagnosed with a first incident cancer. Incidence rates of cancer were 9.8, 10.5, and 10.8 per 1,000 person-years in metformin, ILS, and placebo, respectively, with a HR of 0.90 (95% confidence interval, 0.73-1.10) for metformin compared with placebo and 0.96 (95% confidence interval, 0.79-1.18) for ILS compared with placebo." (abstract, results, passage verified)
pubmedfull study (doi)
Lactate and ketone bodies are thermodynamically favorable energy sources that require less oxygen and fewer ATP molecules to produce energy.
"lactate also is, much like ketone bodies, energetic thermodynamically favorable. So it takes less um energy to make energy. Yeah. So you're consuming less oxygen because you don't need as many ATP molecules to make ATP." (said at 0:33:50)
The speaker's core concept draws on published metabolic research showing that ketone bodies (such as D-β-hydroxybutyrate) and lactate can serve as energetically favorable substrates that improve mitochondrial thermodynamic efficiency. In isolated perfused animal hearts and tissues, ketone body metabolism widens the redox potential between mitochondrial NAD and coenzyme Q, increasing hydraulic work per unit of oxygen consumed and increasing the free energy released from ATP hydrolysis (ΔG_ATP). However, the speaker's phrasing ('you're consuming less oxygen because you don't need as many ATP molecules to make ATP') garbles basic bioenergetics: aerobic ATP production generates ATP from ADP and inorganic phosphate via the electron transport chain using oxygen as the terminal electron acceptor, not by consuming 'ATP to make ATP'. While ketone oxidation is more oxygen-efficient than fatty acid oxidation, evidence for enhanced mechanical efficiency comes predominantly from ex vivo and animal models.
Advanced and severe Lyme disease can present with dementia-like symptoms and neurological manifestations resembling cerebral palsy.
"And if you look at the advanced uh symptoms of severe Lyme, I mean, they it takes on dementia-like uh qualities and like even cerebral palsy in some cases. Really scary stuff." (said at 0:40:01)
Advanced Lyme neuroborreliosis can rarely present with severe cognitive impairment resembling dementia (secondary dementia-like syndrome), which may improve with antibiotic treatment. However, recent large-scale studies show no association between Lyme disease and primary neurodegenerative dementia. While late central nervous system Lyme disease can cause motor deficits, encephalomyelitis, and spasticity that may resemble severe neurological motor impairment, cerebral palsy itself is a non-progressive developmental disorder occurring in early childhood.
- supports: Lyme neuroborreliosis and dementia. (Journal of Alzheimer's disease : JAD 2014) · cited 49x in the literature
"Pure Lyme dementia exists and has a good outcome after antibiotics." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Secondary dementia due to Lyme neuroborreliosis. (Wiener klinische Wochenschrift 2018) · cited 46x in the literature
"Dementia-like syndromes are rare manifestations of Lyme neuroborreliosis." (abstract, passage verified)
pubmedfull study (doi) - supports: Lyme Neuroborreliosis in the Context of Dementia Syndromes. (Cureus 2024) · cited 1x in the literature
"dementia-like syndrome is an infrequent manifestation of Lyme disease." (abstract, passage verified)
pubmedfull study (doi) - context: Neuropsychiatric Manifestations of Lyme Disease: A Literature Review of Psychiatric and Co… (Acta medica Lituanica 2025)
"some studies suggest that Lyme disease can affect the patients' cognitive abilities, leading to impairments in verbal fluency, attention, and memory, with a few isolated dementia-like cases highlighting the need for careful diagnosis. Nevertheless, recent large-scale studies show no increased risk of dementia." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.